Abstract:Human parvovirus B19 (B19V) from the erythrovirus genus is known to be a pathogenic virus in humans. Prevalence of B19V infection has been reported worldwide in all seasons, with a high incidence in the spring. B19V is responsible for erythema infectiosum (fifth disease) commonly seen in children. Its other clinical presentations include arthralgia, arthritis, transient aplastic crisis, chronic anemia, congenital anemia, and hydrops fetalis. In addition, B19V infection has been reported to trigger autoimmune diseases such as systemic lupus erythematosus and rheumatoid arthritis. However, the mechanisms of B19V participation in autoimmunity are not fully understood. B19V induced chronic disease and persistent infection suggests B19V can serve as a model for viral host interactions and the role of viruses in the pathogenesis of autoimmune diseases. Here we investigate the involvement of B19V in the breakdown of immune tolerance. Previously, we demonstrated that the non-structural protein 1 (NS 1) of B19V induces apoptosis in non-permissive cells lines and that this protein can cleave host DNA as well as form NS1-DNA adducts. Here we provide evidence that through programmed cell death, apoptotic bodies (ApoBods) are generated by B19V NS1 expression in a non-permissive cell line. Characterization of purified ApoBods identified potential self-antigens within them. In particular, signature self-antigens such as Smith, ApoH, DNA, histone H4 and phosphatidylserine associated with autoimmunity were present in these ApoBods. In addition, when purified ApoBods were introduced to differentiated macrophages, recognition, engulfment and uptake occurred. This suggests that B19V can produce a source of self-antigens for immune cell processing. The results support our hypothesis that B19V NS1-DNA adducts, and nucleosomal and lysosomal antigens present in ApoBods created in non-permissive cell lines, are a source of self-antigens.

Experimental Autoimmune Thyroiditis in Human Parvovirus B19 Transgenic Mice.

CMV-hFasL Transgenic Mice Prevent from Experimental Autoimmune Thyroiditis.

Parvovirus B19 Infection Associated with Hashimoto's Thyroiditis in Adults

Effect of Natural Viral Infection on T-cell Depression and Autoantibody Production in Spontaneously Hypertensive Rats (SHR)

Gene Therapy of Experimental Autoimmune Thyroiditis Mice by in Vivo Administration of Plasmid Dna Coding for Human Interleukin-10

Detection and a possible link between parvovirus B19 and thyroid cancer

PRDM1 Expression Via Human Parvovirus B19 Infection Plays a Role in the Pathogenesis of Hashimoto Thyroiditis.

The role of parvovirus B19 in the pathogenesis of autoimmunity and autoimmune disease

[Review of correlation between human parvovirus B19 and autoimmune disease etiology]

Human parvovirus B19 induced apoptotic bodies contain altered self-antigens that are phagocytosed by antigen presenting cells

Viral infection and innate pattern recognition receptors in induction of Hashimoto's thyroiditis

Human parvovirus B19 NS1 protein aggravates liver injury in NZB/W F1 mice

Increased expression of Matrix Metalloproteinase 9 in liver from NZB/W F1 mice received antibody against human parvovirus B19 VP1 unique region protein

Increased cardiac injury in NZB/W F1 mice received antibody against human parvovirus B19 VP1 unique region protein

Detection of Human Parvovirus B19 in Papillary Thyroid Carcinoma

Exacerbating effects of human parvovirus B19 NS1 on liver fibrosis in NZB/W F1 mice

High Prevalence of Common Human Viruses in Thyroid Tissue

Human parvovirus B19 and autoimmune diseases. Review of the literature and pathophysiological hypotheses

Human Parvovirus B19 May Be a Risk Factor in Myasthenia Gravis with Thymoma

Parvovirus B19 infection associated with hemolytic anemia and cranial polyneuropathy

Effect of the Functional VP1 Unique Region of Human Parvovirus B19 in Causing Skin Fibrosis of Systemic Sclerosis